The Cromer blood group system: an update

1. Storry JR, Reid ME, Yazer MH. The Cromer blood group system: a review. Immunohematology 2010;26:109–18. Storry JR Reid ME Yazer MH. The Cromer blood group system: a review . Immunohematology 2010 ; 26 : 109 – 18 . 10.21307/immunohematology-2019-210 Search in Google Scholar

2. Telen MJ, Rao N, Udani M, Thompson ES, Kaufman RM, Lublin DM. Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 1994;84:3205–11. Telen MJ Rao N Udani M Thompson ES Kaufman RM Lublin DM. Molecular mapping of the Cromer blood group Cr^a and Tc^a epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology . Blood 1994 ; 84 : 3205 – 11 . 10.1182/blood.V84.9.3205.3205 Search in Google Scholar

3. Lublin DM, Mallinson G, Poole J, et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994;84:1276–82. Lublin DM Mallinson G Poole J Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes . Blood 1994 ; 84 : 1276 – 82 . 10.1182/blood.V84.4.1276.1276 Search in Google Scholar

4. Lublin DM, Kompelli S, Storry JR, Reid ME. Molecular basis of Cromer blood group antigens. Transfusion 2000;40:208–13. Lublin DM Kompelli S Storry JR Reid ME. Molecular basis of Cromer blood group antigens . Transfusion 2000 ; 40 : 208 – 13 . 10.1046/j.1537-2995.2000.40020208.x10686005 Search in Google Scholar

5. Storry JR, Sausais L, Hue-Roye K, et al. GUTI: a new antigen in the Cromer blood group system. Transfusion 2003;43:340–4. Storry JR Sausais L Hue-Roye K GUTI: a new antigen in the Cromer blood group system . Transfusion 2003 ; 43 : 340 – 4 . 10.1046/j.1537-2995.2003.00319.x12675719 Search in Google Scholar

6. Banks J, Poole J, Ahrens N, et al. SERF: a new antigen in the Cromer blood group system. Transfus Med 2004;14:313–8. Banks J Poole J Ahrens N SERF: a new antigen in the Cromer blood group system . Transfus Med 2004 ; 14 : 313 – 8 . 10.1111/j.0958-7578.2004.00519.x15285728 Search in Google Scholar

7. Hue-Roye K, Lomas-Francis C, Belaygorod L, et al. Three new high-prevalence antigens in the Cromer blood group system. Transfusion 2007;47:1621–9. Hue-Roye K Lomas-Francis C Belaygorod L Three new high-prevalence antigens in the Cromer blood group system . Transfusion 2007 ; 47 : 1621 – 9 . 10.1111/j.1537-2995.2007.01333.x17725726 Search in Google Scholar

8. Karamatic Crew V, Poole J, Thornton N, et al. Two unusual cases within the Cromer blood group system: I) a novel high incidence antigen Croz and II) a novel molecular basis of Inab phenotype. Transfus Med 2010;20(Suppl 1):12. Karamatic Crew V Poole J Thornton N Two unusual cases within the Cromer blood group system: I) a novel high incidence antigen Croz and II) a novel molecular basis of Inab phenotype . Transfus Med 2010 ; 20 ( Suppl 1 ): 12 . Search in Google Scholar

9. Karamatic Crew V, Poole J, Mathlouthi R, Wall L, Daniels G. A novel Cromer blood group system antigen, CRUE, arising from two heterozygous DAF mutations in one individual with the corresponding anti-CRUE. Vox Sang 2012;103(Suppl 1):56. Karamatic Crew V Poole J Mathlouthi R Wall L Daniels G. A novel Cromer blood group system antigen, CRUE, arising from two heterozygous DAF mutations in one individual with the corresponding anti-CRUE . Vox Sang 2012 ; 103 ( Suppl 1 ): 56 . Search in Google Scholar

10. Lomas-Francis C, Fuchisawa A, Hamilton J, Hue-Roye K, Pelton SB, Westhoff CM. CRAG: a new high-prevalence antigen in the Cromer blood group system. Vox Sang 2012;103(Suppl 1):211–2. Lomas-Francis C Fuchisawa A Hamilton J Hue-Roye K Pelton SB Westhoff CM. CRAG: a new high-prevalence antigen in the Cromer blood group system . Vox Sang 2012 ; 103 ( Suppl 1 ): 211 – 2 . Search in Google Scholar

11. Yahalom V, Finkel L, Poole J, et al. CROK—a novel mutation of the Cromer blood group system. Vox Sang 2012;103(Suppl 1):212. Yahalom V Finkel L Poole J CROK—a novel mutation of the Cromer blood group system . Vox Sang 2012 ; 103 ( Suppl 1 ): 212 . Search in Google Scholar

12. Vrignaud C, Chiaroni J, Landre C, et al. Characterization of a novel high-prevalence antigen in the Cromer blood group system. Vox Sang 2018;113(Suppl 1):64–5. Vrignaud C Chiaroni J Landre C Characterization of a novel high-prevalence antigen in the Cromer blood group system . Vox Sang 2018 ; 113 ( Suppl 1 ): 64 – 5 . Search in Google Scholar

13. Lomas-Francis C, Wu Y, Fuchisawa A, et al. A new molecular basis (c.148G>T in DAF) for the Cromer-null phenotype in a Yt(a–) MER2 (CROM) proband with anti-IFC. Transfusion 2013;43(Suppl):41A. Lomas-Francis C Wu Y Fuchisawa A A new molecular basis (c.148G>T in DAF) for the Cromer-null phenotype in a Yt(a–) MER2 (CROM) proband with anti-IFC . Transfusion 2013 ; 43 ( Suppl ): 41A . Search in Google Scholar

14. Holmes CH, Simpson KL, Wainwright SD, et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 1990;144:3099–105. Holmes CH Simpson KL Wainwright SD Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy . J Immunol 1990 ; 144 : 3099 – 105 . 10.4049/jimmunol.144.8.3099 Search in Google Scholar

15. Reid ME, Chandrasekaran V, Sausais L, Pierre J, Bullock R. Disappearance of antibodies to Cromer blood group system antigens during mid pregnancy. Vox Sang 1996;71:48–50. Reid ME Chandrasekaran V Sausais L Pierre J Bullock R. Disappearance of antibodies to Cromer blood group system antigens during mid pregnancy . Vox Sang 1996 ; 71 : 48 – 50 . 10.1046/j.1423-0410.1996.7110048.x8837357 Search in Google Scholar

16. Banadakoppa M, Chauhan MS, Havemann D, Balakrishnan M, Dominic JS, Yallampalli C. Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta. Clin Exp Immunol 2014;177:743–9. Banadakoppa M Chauhan MS Havemann D Balakrishnan M Dominic JS Yallampalli C. Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta . Clin Exp Immunol 2014 ; 177 : 743 – 9 . 10.1111/cei.12371413785924802103 Search in Google Scholar

17. Regal JF, Gilbert JS, Burwick RM. The complement system and adverse pregnancy outcomes. Mol Immunol 2015;67: 56–70. Regal JF Gilbert JS Burwick RM. The complement system and adverse pregnancy outcomes . Mol Immunol 2015 ; 67 : 56 – 70 . 10.1016/j.molimm.2015.02.030444755425802092 Search in Google Scholar

18. Egan ES, Jiang RH, Moechtar MA, et al. Malaria: a forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion. Science 2015;348:711–4. Egan ES Jiang RH Moechtar MA Malaria: a forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion . Science 2015 ; 348 : 711 – 4 . 10.1126/science.aaa3526446543425954012 Search in Google Scholar

19. Ozen A, Comrie WA, Lenardo MJ. CD55 deficiency and protein-losing enteropathy. N Engl J Med 2017;377:1499–500. Ozen A Comrie WA Lenardo MJ. CD55 deficiency and protein-losing enteropathy . N Engl J Med 2017 ; 377 : 1499 – 500 . 10.1056/NEJMc171001129020581 Search in Google Scholar

20. Angeletti A, Marasa M, Cravedi P. CD55 deficiency and protein-losing enteropathy. N Engl J Med 2017;377:1499. Angeletti A Marasa M Cravedi P. CD55 deficiency and protein-losing enteropathy . N Engl J Med 2017 ; 377 : 1499 . 10.1056/NEJMc1710011 Search in Google Scholar